Table 3 Univariate prognostic analysis for non-pCR patients with colorectal cancer (n = 246)
Clinicopathologic Features | n | 5-year overall survival rate | Hazard ratio (95% CI) | P-value |
|---|---|---|---|---|
Age (yrs) | 0.714 (0.438–1.162) | 0.171 | ||
< 60 | 132 | 60.5% | ||
≥ 60 | 114 | 69.0% | ||
Sex | 0.943 (0.556–1.599) | 0.826 | ||
Male | 177 | 61.5% | ||
Female | 69 | 69.8% | ||
Primary tumor Diameter | 1.254 (0.779–2.020) | 0.348 | ||
< 3 cm | 117 | 70.1% | ||
≥ 3 cm | 129 | 57.4% | ||
Macroscopic type | 1.406 (0.607–3.259) | 0.422 | ||
Exophytic type | 222 | 68.8% | ||
Ulcerative type | 24 | 64.2% | ||
Histological differentiation | 1.771 (0.985–3.186) | 0.052 | ||
Well to moderately | 214 | 67.3% | ||
Poorly | 32 | 45.0% | ||
Clinical TNM stage | 1.811 (1.084–3.025) | 0.021* | ||
II | 102 | 71.2% | ||
III | 144 | 59.0% | ||
Neoadjuvant pathologic TNM stage | 2.704 (1.811–4.038) | < 0.001* | ||
I | 51 | 96.0% | ||
II | 94 | 66.4% | ||
III | 101 | 49.7% |